Today I'm speaking with Dr. Mark Pimentel and of course, he's no stranger to anyone in the SIBO community. He's been really instrumental in many IBS and SIBO studies and a lot of research that's been happening over the last few years. I learned about Dr. Pimentel through his book, The New IBS Solution, about 10 years ago. He is the executive director of the Medically Associated Science and Technology program at Cedars-Sinai. He's a professor of medicine at Geffen School of Medicine and associate professor of Cedars-Sinai Medical Center in Los Angeles. He's very active in research and has served as a principal investigator or co-investigator for numerous clinical studies. And of course we know him as the developer or discoverer of the anti-vinculin and anti-CdtB antibodies that predict whether or not you have SIBO or autoimmune IBS. He also discovered the use of Lovastatin for methanogens.